{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:14:59Z","timestamp":1793330099077,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K18098"],"award-info":[{"award-number":["JP20K18098"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80411-4","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T19:32:25Z","timestamp":1732217545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Suppression of renal crystal formation, inflammation, and fibrosis by blocking oncostatin M receptor \u03b2 signaling"],"prefix":"10.1038","volume":"14","author":[{"given":"Ryusuke","family":"Deguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadasuke","family":"Komori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Hisaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Kajimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Kohjimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"80411_CR1","doi-asserted-by":"crossref","first-page":"16008","DOI":"10.1038\/nrdp.2016.8","volume":"2","author":"SR Khan","year":"2016","unstructured":"Khan, S. R. et al. Kidney stones. Nat. Rev. Dis. Primers 2, 16008 (2016).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"80411_CR2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41581-020-0320-7","volume":"16","author":"C Thongprayoon","year":"2020","unstructured":"Thongprayoon, C., Krambeck, A. E. & Rule, A. D. Determining the true burden of kidney stone disease. Nat. Rev. Nephrol. 16, 736\u2013746 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"80411_CR3","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1681\/ASN.2013091011","volume":"25","author":"AD Rule","year":"2014","unstructured":"Rule, A. D. et al. The ROKS nomogram for predicting a second symptomatic stone episode. J. Am. Soc. Nephrol. 25, 2878\u20132886 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"80411_CR4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.mayocp.2018.09.016","volume":"94","author":"LE Vaughan","year":"2019","unstructured":"Vaughan, L. E. et al. Predictors of symptomatic kidney stone recurrence after the first and subsequent episodes. Mayo Clin. Proc. 94, 202\u2013210 (2019).","journal-title":"Mayo Clin. Proc."},{"key":"80411_CR5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/MNH.0b013e32836214b9","volume":"22","author":"MT Keddis","year":"2013","unstructured":"Keddis, M. T. & Rule, A. D. Nephrolithiasis and loss of kidney function. Curr. Opin. Nephrol. Hypertens. 22, 390\u2013396 (2013).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"80411_CR6","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.2015.254","volume":"88","author":"AL Zisman","year":"2015","unstructured":"Zisman, A. L., Evan, A. P., Coe, F. L. & Worcester, E. M. Do kidney stone formers have a kidney disease? Kidney Int. 88, 1240\u20131249 (2015).","journal-title":"Kidney Int."},{"key":"80411_CR7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41581-021-00513-4","volume":"18","author":"P Singh","year":"2022","unstructured":"Singh, P., Harris, P. C., Sas, D. J. & Lieske, J. C. The genetics of kidney stone disease and nephrocalcinosis. Nat. Rev. Nephrol. 18, 224\u2013240 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"80411_CR8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s11255-018-1849-2","volume":"50","author":"A Khan","year":"2018","unstructured":"Khan, A. Prevalence, pathophysiological mechanisms and factors affecting urolithiasis. Int. Urol. Nephrol. 50, 799\u2013806 (2018).","journal-title":"Int. Urol. Nephrol."},{"key":"80411_CR9","first-page":"75","volume":"8","author":"SR Khan","year":"2004","unstructured":"Khan, S. R. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin. Exp. Nephrol. 8, 75\u201388 (2004).","journal-title":"Clin. Exp. Nephrol."},{"key":"80411_CR10","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0002-9440(10)64634-2","volume":"157","author":"C Langdon","year":"2000","unstructured":"Langdon, C. et al. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am. J. Pathol. 157, 1187\u20131196 (2000).","journal-title":"Am. J. Pathol."},{"key":"80411_CR11","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.4049\/jimmunol.1203318","volume":"191","author":"FM Botelho","year":"2013","unstructured":"Botelho, F. M. et al. Pulmonary expression of oncostatin M (OSM) promotes inducible BALT formation independently of IL-6, despite a role for IL-6 in OSM-driven pulmonary inflammation. J. Immunol. 191, 1453\u20131464 (2013).","journal-title":"J. Immunol."},{"key":"80411_CR12","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/eji.201546216","volume":"46","author":"M Pohin","year":"2016","unstructured":"Pohin, M. et al. Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation. Eur. J. Immunol. 46, 1737\u20131751 (2016).","journal-title":"Eur. J. Immunol."},{"key":"80411_CR13","doi-asserted-by":"crossref","first-page":"e23359","DOI":"10.1096\/fj.202301529R","volume":"38","author":"T Komori","year":"2024","unstructured":"Komori, T. et al. Blockade of OSMR\u03b2 signaling ameliorates skin lesions in a mouse model of human atopic dermatitis. FASEB J. 38, e23359 (2024).","journal-title":"FASEB J."},{"key":"80411_CR14","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1002\/art.22161","volume":"54","author":"U Fearon","year":"2006","unstructured":"Fearon, U. et al. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum. 54, 3152\u20133162 (2006).","journal-title":"Arthritis Rheum."},{"key":"80411_CR15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm.4307","volume":"23","author":"NR West","year":"2017","unstructured":"West, N. R. et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat. Med. 23, 579\u2013589 (2017).","journal-title":"Nat. Med."},{"key":"80411_CR16","doi-asserted-by":"crossref","first-page":"eabf8188","DOI":"10.1126\/scitranslmed.abf8188","volume":"14","author":"SE Headland","year":"2022","unstructured":"Headland, S. E. et al. Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma. Sci. Transl. Med. 14, eabf8188 (2022).","journal-title":"Sci. Transl. Med."},{"key":"80411_CR17","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.4049\/jimmunol.181.10.7243","volume":"181","author":"A Mozaffarian","year":"2008","unstructured":"Mozaffarian, A. et al. Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis. J. Immunol. 181, 7243\u20137253 (2008).","journal-title":"J. Immunol."},{"key":"80411_CR18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.29421","volume":"67","author":"M Matsuda","year":"2018","unstructured":"Matsuda, M. et al. Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice. Hepatology 67, 296\u2013312 (2018).","journal-title":"Hepatology"},{"key":"80411_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.ASN.0000102479.92582.43","volume":"15","author":"J Nightingale","year":"2004","unstructured":"Nightingale, J. et al. Oncostatin M, a cytokine released by activated mononuclear cells, induces epithelial cell-myofibroblast transdifferentiation via Jak\/Stat pathway activation. J. Am. Soc. Nephrol. 15, 21\u201332 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"80411_CR20","doi-asserted-by":"crossref","first-page":"F1714","DOI":"10.1152\/ajprenal.00130.2007","volume":"293","author":"V Pollack","year":"2007","unstructured":"Pollack, V. et al. Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling. Am. J. Physiol. Renal Physiol. 293, F1714\u2013F1726 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"80411_CR21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/jir.2009.0105","volume":"30","author":"WM Elbjeirami","year":"2010","unstructured":"Elbjeirami, W. M. et al. Early differential expression of oncostatin M in obstructive nephropathy. J. Interferon Cytokine Res. 30, 513\u2013523 (2010).","journal-title":"J. Interferon Cytokine Res."},{"key":"80411_CR22","doi-asserted-by":"crossref","first-page":"F875","DOI":"10.1152\/ajprenal.90633.2008","volume":"296","author":"VA Luyckx","year":"2009","unstructured":"Luyckx, V. A., Cairo, L. V., Compston, C. A., Phan, W. L. & Mueller, T. F. Oncostatin M pathway plays a major role in the renal acute phase response. Am. J. Physiol. Renal Physiol. 296, F875\u2013F883 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"80411_CR23","doi-asserted-by":"crossref","first-page":"F777","DOI":"10.1152\/ajprenal.00418.2012","volume":"305","author":"I S\u00f6rensen-Zender","year":"2013","unstructured":"S\u00f6rensen-Zender, I. et al. Role of fibrinogen in acute ischemic kidney injury. Am. J. Physiol. Renal Physiol. 305, F777\u2013F785 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"80411_CR24","doi-asserted-by":"crossref","first-page":"17150","DOI":"10.1038\/s41598-020-74198-3","volume":"10","author":"S Yamashita","year":"2020","unstructured":"Yamashita, S. et al. Essential roles of oncostatin M receptor \u03b2 signaling in renal crystal formation in mice. Sci. Rep. 10, 17150 (2020).","journal-title":"Sci. Rep."},{"key":"80411_CR25","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/1529-0131(200111)44:11<2697::AID-ART450>3.0.CO;2-#","volume":"44","author":"C Plater-Zyberk","year":"2001","unstructured":"Plater-Zyberk, C. et al. Amelioration of arthritis in two murine models using antibodies to oncostatin M. Arthritis Rheum. 44, 2697\u20132702 (2001).","journal-title":"Arthritis Rheum."},{"key":"80411_CR26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cytogfr.2015.07.006","volume":"26","author":"HM Hermanns","year":"2015","unstructured":"Hermanns, H. M. Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology. Cytokine Growth Factor Rev. 26, 545\u2013558 (2015).","journal-title":"Cytokine Growth Factor Rev."},{"key":"80411_CR27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00240-007-0082-8","volume":"35","author":"A Okada","year":"2007","unstructured":"Okada, A. et al. Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection. Urol. Res. 35, 89\u201399 (2007).","journal-title":"Urol. Res."},{"key":"80411_CR28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00240-012-0514-y","volume":"40","author":"K Kohri","year":"2012","unstructured":"Kohri, K. et al. Biomolecular mechanism of urinary stone formation involving osteopontin. Urol. Res. 40, 623\u2013637 (2012).","journal-title":"Urol. Res."},{"key":"80411_CR29","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1021\/pr3000738","volume":"11","author":"S Chutipongtanate","year":"2012","unstructured":"Chutipongtanate, S., Fong-ngern, K., Peerapen, P. & Thongboonkerd, V. High calcium enhances calcium oxalate crystal binding capacity of renal tubular cells via increased surface annexin A1 but impairs their proliferation and healing. J. Proteome Res. 11, 3650\u20133663 (2012).","journal-title":"J. Proteome Res."},{"key":"80411_CR30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.ASN.0000046030.24938.0A","volume":"14","author":"V Kumar","year":"2003","unstructured":"Kumar, V., Farell, G., Deganello, S. & Lieske, J. C. Annexin II is present on renal epithelial cells and binds calcium oxalate monohydrate crystals. J. Am. Soc. Nephrol. 14, 289\u2013297 (2003).","journal-title":"J. Am. Soc. Nephrol."},{"key":"80411_CR31","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.273.7.4135","volume":"273","author":"T Ichimura","year":"1998","unstructured":"Ichimura, T. et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273, 4135\u20134142 (1998).","journal-title":"J. Biol. Chem."},{"key":"80411_CR32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MOU.0000000000001066","volume":"33","author":"G Capolongo","year":"2023","unstructured":"Capolongo, G., Ferraro, P. M. & Unwin, R. Inflammation and kidney stone: cause and effect? Curr. Opin. Urol. 33, 129\u2013135 (2023).","journal-title":"Curr. Opin. Urol."},{"key":"80411_CR33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1681\/ASN.2015111271","volume":"28","author":"K Taguchi","year":"2017","unstructured":"Taguchi, K. et al. Genome-wide gene expression profiling of Randall\u2019s plaques in calcium oxalate stone formers. J. Am. Soc. Nephrol. 28, 333\u2013347 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"80411_CR34","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1681\/ASN.2013060675","volume":"25","author":"K Taguchi","year":"2014","unstructured":"Taguchi, K. et al. Colony-stimulating factor-1 signaling suppresses renal crystal formation. J. Am. Soc. Nephrol. 25, 1680\u20131697 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"80411_CR35","doi-asserted-by":"crossref","first-page":"35167","DOI":"10.1038\/srep35167","volume":"6","author":"K Taguchi","year":"2016","unstructured":"Taguchi, K. et al. M1\/M2-macrophage phenotypes regulate renal calcium oxalate crystal development. Sci. Rep. 6, 35167 (2016).","journal-title":"Sci. Rep."},{"key":"80411_CR36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2023.09.001","volume":"35","author":"N Yamashita","year":"2024","unstructured":"Yamashita, N. & Kramann, R. Mechanisms of kidney fibrosis and routes towards therapy. Trends Endocrinol. Metab. 35, 31\u201348 (2024).","journal-title":"Trends Endocrinol. Metab."},{"key":"80411_CR37","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.4049\/jimmunol.173.7.4360","volume":"173","author":"E Esashi","year":"2004","unstructured":"Esashi, E. et al. Development of CD4+ macrophages from intrathymic T cell progenitors is induced by thymic epithelial cells. J. Immunol. 173, 4360\u20134367 (2004).","journal-title":"J. Immunol."},{"key":"80411_CR38","doi-asserted-by":"crossref","first-page":"21861","DOI":"10.1074\/jbc.M113.461905","volume":"288","author":"T Komori","year":"2013","unstructured":"Komori, T., Tanaka, M., Senba, E., Miyajima, A. & Morikawa, Y. Lack of oncostatin M receptor \u03b2 leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype. J. Biol. Chem. 288, 21861\u201321875 (2013).","journal-title":"J. Biol. Chem."},{"key":"80411_CR39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/12.5.333","volume":"12","author":"P Pizzolato","year":"1964","unstructured":"Pizzolato, P. Histochemical recognition of calcium oxalate. J. Histochem. Cytochem. 12, 333\u2013336 (1964).","journal-title":"J. Histochem. Cytochem."},{"key":"80411_CR40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01002772","volume":"11","author":"LC Junqueira","year":"1979","unstructured":"Junqueira, L. C. U., Bignolas, G. & Brentani, R. R. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem. J. 11, 447\u2013455 (1979).","journal-title":"Histochem. J."},{"key":"80411_CR41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s10020-021-00285-4","volume":"27","author":"KH Kim","year":"2021","unstructured":"Kim, K. H. et al. IL-17 deficiency aggravates the streptozotocin-induced diabetic nephropathy through the reduction of autophagosome formation in mice. Mol. Med. 27, 25 (2021).","journal-title":"Mol. Med."},{"key":"80411_CR42","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41420-022-01188-x","volume":"8","author":"QY Zheng","year":"2022","unstructured":"Zheng, Q. Y. et al. LIGHT deficiency attenuates acute kidney disease development in an in vivo experimental renal ischemia and reperfusion injury model. Cell Death Discov. 8, 399 (2022).","journal-title":"Cell Death Discov."},{"key":"80411_CR43","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1046\/j.1523-1755.2002.00328.x","volume":"61","author":"K Nagatoya","year":"2002","unstructured":"Nagatoya, K. et al. Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 61, 1684\u20131695 (2002).","journal-title":"Kidney Int."},{"key":"80411_CR44","doi-asserted-by":"crossref","first-page":"102686","DOI":"10.1016\/j.jbc.2022.102686","volume":"298","author":"T Komori","year":"2022","unstructured":"Komori, T. & Morikawa, Y. Essential roles of the cytokine oncostatin M in crosstalk between muscle fibers and immune cells in skeletal muscle after aerobic exercise. J. Biol. Chem. 298, 102686 (2022).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80411-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80411-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80411-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T18:06:42Z","timestamp":1735582002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80411-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80411"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80411-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T. Komori and Y. Morikawa are the inventors on a patent for the use of anti-OSMR\u03b2 antibody (7D2) in treatment of atopic dermatitis (US9475876B2; JP6214010). T. Komori, S. Yamashita, Y. Kohjimoto, I. Hara, and Y. Morikawa have a patent pending on the use of anti-OSMR\u03b2 antibody (7D2) in treatment of kidney stone disease. All other authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28913"}}